Young Rok Do

A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study

H. Eom, J. Jo, Deok-Hwan Yang, 2023, Blood research.

Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial

Deok-Hwan Yang, J. Byun, J. Kwak, 2024, Nature communications.

Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era

H. Yhim, D. Baek, Ho-Sup Lee, 2024, Frontiers in oncology.

Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study

H. Yhim, J. Kwak, D. Kim, 2024, The Korean journal of internal medicine.